ROSEN, GLOBAL INVESTOR COUNSEL, encourages Regeneron Pharmaceuticals, Inc. investors to seek legal counsel before the important deadline in a securities class action lawsuit

New York, New York – (Newsfile Corp. – January 25, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron (NASDAQ:) Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30,…